Investor Presentaiton

Wuxi ATU Manufacturing Platform Roadmap Defining CGT Future Manufacturing Standard to Drive Down Cost Automate & Scale Up Collaborating with automation companies to develop fully automated cell manufacturing system Innovate & Create ATU internally develops closed system for cell manufacturing Improve & Optimize Clients' process transferred to ATU and ATU improve and optimize the process for GMP manufacturing & testing السا $ 000 Drove down mfg cost by 40% for a cell therapy product from clinical scale to commercial scale mfg ⚫ For a viral vector product, reduced mfg cost by >50% Using TESSA technology, we can drive down AAV mfg cost by 10 folds per dose

View entire presentation